NEW YORK, Nov. 6 – Pyrosequencing and Genomics Collaborative said Tuesday that they had agreed to jointly collaborate to generate genomic information that could be used to develop diagnostics and therapeutic products for cardiovascular disease.

The deal is Pyrosequencing’s second such deal in the diagnostics market in as many days. On Monday, the Uppsala, Sweden-based company announced that it would work with the Cleveland Clinic to co-develop rapid identification and diagnostic tests for mycobacteria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.